Sumiko Watanabe

9PUBLICATIONS
3CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 07, 2026
Attenuation of Oxygen-Induced Neovascularization and Inflammation by Neutralizing VEGFA and/or ANG-2 With an Antibody.

Hirokazu Oohashi, Toshiro Iwagawa, Hiroto Abe

|Jun 25, 2025
Effects of Dual Inhibition of VEGF-A and Angpt-2 on Angiogenesis and Lymphangiogenesis in an Alkali-Induced Corneal Injury Model.

Hiroshi Kuribayashi, Toshiro Iwagawa, Souta Kadohara

|Jun 24, 2025
Effects of VEGFA and ANGPT2 Antibodies on the Activation of Microglia in the Early Stages of Streptozotocin-Induced Pathogenesis of Diabetic Retinopathy.

Toshiro Iwagawa, Yuta Inokuchi, Kosuke Saita

|Apr 19, 2023
The histone H3K36 demethylase Fbxl11 plays pivotal roles in the development of retinal late-born cell types.

Toshiro Iwagawa, Masaya Fukushima, Shigeru Takeuchi

|Nov 02, 2022
Loss-of-function approach using mouse retinal explants showed pivotal roles of Nmnat2 in early and middle stages of retinal development.

Hiroshi Kuribayashi, Miku Katahira, Makoto Aihara

|Apr 12, 2020
Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.

Xiaoyue Deng, Toshiro Iwagawa, Masaya Fukushima

Pageof 2